Overview
Download factsheetWhat does the Fund do?
It seeks global, high-quality businesses that have the resilience to survive adversity and the adaptability to thrive in a changing world. Businesses that can grow at sustainably high returns over time provide longevity and compounding power to your returns.
Why this Fund?
Aimed at investors who seek exposure to enduring businesses with stable cashflow, strong management teams and a culture of innovation. The Fund integrates ESG and stewardship in accordance with Troy’s Responsible Investment & Stewardship Policy and also adheres to Troy’s Climate Change Mitigation Policy, in accordance with article 8 of SFDR.
View our SFDR disclosure
The team
Key facts
Co-Manager
Gabrielle Boyle
Co-Manager
George Viney
Strategy Inception date
06/03/2006
Currency
Sterling
Available share classes
O GBP Acc and Inc
O EUR Acc and Inc
O USD Acc and Inc
I GBP Acc and Inc
I EUR Acc and Inc
S GBP Acc and Inc
ISIN (O GBP Class)
IE000B0QOAR7 (Inc)
IE000ALQZ5E5 (Acc)
Bloomberg (O GBP Class)
TRCOGIN ID (Inc)
TRCLOGA ID (Acc)
Sedol (O GBP Class)
BMCHXB4 (Inc)
BMCHX92 (Acc)
Benchmarks
For more information on the benchmarks used please refer to the ‘use of benchmarks’ section in the fund information sheet
Ongoing Charges
‘O’ (ordinary) shares: 0.86%
‘O’ ACC SHARE CLASS as at 18/12/2024
£6.481
Fund size as at 31/08/2026
£395m
‘O’ INC SHARE CLASS as at 18/12/2024
£5.3206
Performance
Source: Lipper. Past performance is taken from the corresponding share class of the Trojan Global Equity Fund which merged with the Trojan Global Equity Fund (Ireland) on 13 December 2024. Trojan Global Equity Fund was domiciled in the UK and authorised as a UK UCITS, which was originally launched as the Trojan Capital Fund, focused on investing in UK equities with the flexibility to invest in overseas equities and other asset classes. The strategy was changed to a global equity strategy in December 2013. The Fund has been a constituent of the IA Global sector since April 2012.
| 06/03/2006 | 31/08/2016 | 31/08/2021 | 31/08/2023 | 31/08/2025 | 28/02/2026 | |
|---|---|---|---|---|---|---|
| Since Launch | 10 Years | 5 Years | 3 Years | 1 Year | 6 Months | |
| MSCI World NR GBP | 617.9 | 228.1 | 72.7 | 61.9 | 20.0 | 8.9 |
| IA Global TR | 418.8 | 164.3 | 42.7 | 46.4 | 16.9 | 6.6 |
| Trojan Global Equity O GBP Acc | 524.7 | 134.3 | 16.8 | 18.0 | -3.5 | 4.7 |
| Discrete Calendar Annual Returns (%) | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Trojan Global Equity O GBP Acc | 20.2 | -4.4 | -11 | 18.8 | 15.2 | 6.3 | 3.9 | 14.6 | 15.1 | 12.4 | 19.3 | 13.2 | 1.1 | 24.6 | 13.5 | 21.7 | -15.7 | 23.9 | 16 | 0 | -4.3 |
Performance is calculated on a total return basis, net of fees, in sterling terms. Past performance is not a guide to future performance
Source: Lipper. Since Launch (06/03/2006) to 31 August 2026.
Risk and Volatility since launch
Source: Lipper.
| Risk Analysis Since Launch (06/03/2006) | Trojan Global Equity O GBP Acc | IA Global TR | MSCI World NR GBP |
|---|---|---|---|
| Total Return | 524.7 | 418.8 | 617.9 |
| Max Drawdown | -32.9 | -38.3 | -38.3 |
| Best Month | 9.4 | 9.8 | 10.1 |
| Worst Month | -9.4 | -12.9 | -10.6 |
| Positive Months | 60.4 | 63.3 | 63.7 |
| Annualised Volatility | 11.6 | 13.0 | 13.0 |
Performance is calculated on a total return basis, net of fees, in sterling terms.
Maximum Drawdown measures the worst investment period
Annualised Volatility is measured by the annualised standard deviation of the monthly returns
Source: Lipper.
As at 31 August 2026.
Asset allocation
| Top 10 holdings | Fund % |
|---|---|
| Visa | 8.0868896450888 |
| Mastercard | 7.56355050102845 |
| Experian | 6.35155647410361 |
| Microsoft | 6.15123706836652 |
| Alphabet | 5.71635071699441 |
| Amazon com | 5.11199839177733 |
| Amadeus | 4.82560458744745 |
| Roche | 4.64652759745691 |
| Booking | 4.5795624117999 |
| LSEG | 4.56891750778004 |
| Total Top 10 | 57.6021949018434 |
| 15 Other Equity holdings | 41.4719756410543 |
| Cash | 0.92582945710234 |
| Total | 100 |
Asset allocation and holdings subject to change. As at 31 August 2026.
Fund literature
-
Factsheet
View archive Hide archive Open
Download
- Factsheet August 2026 Open Download
- Factsheet July 2026 Open Download
- Factsheet June 2026 Open Download
- Factsheet May 2026 Open Download
- Factsheet April 2026 Open Download
- Factsheet March 2026 Open Download
- Factsheet February 2026 Open Download
- Factsheet January 2026 Open Download
- Factsheet December 2025 Open Download
- Factsheet November 2025 Open Download
- Factsheet October 2025 Open Download
- Factsheet September 2025 Open Download
- Factsheet August 2025 Open Download
- Factsheet July 2025 Open Download
- Factsheet June 2025 Open Download
- Factsheet May 2025 Open Download
- Factsheet April 2025 Open Download
- Factsheet March 2025 Open Download
- Factsheet February 2025 Open Download
- Factsheet January 2025 Open Download
- Factsheet December 2024 Open Download
- Factsheet November 2024 Open Download
- Factsheet October 2024 Open Download
- Factsheet September 2024 Open Download
- Factsheet August 2024 Open Download
- Factsheet July 2024 Open Download
- Factsheet June 2024 Open Download
- Factsheet May 2024 Open Download
- Factsheet April 2024 Open Download
- Factsheet March 2024 Open Download
- Factsheet February 2024 Open Download
- Factsheet January 2024 Open Download
- Factsheet December 2023 Open Download
- Factsheet November 2023 Open Download
- Factsheet October 2023 Open Download
- Factsheet September 2023 Open Download
- Factsheet August 2023 Open Download
- Factsheet July 2023 Open Download
- Factsheet June 2023 Open Download
- Factsheet May 2023 Open Download
- Factsheet April 2023 Open Download
- Factsheet March 2023 Open Download
- Factsheet February 2023 Open Download
- Factsheet January 2023 Open Download
- Factsheet December 2022 Open Download
- Factsheet November 2022 Open Download
- Factsheet October 2022 Open Download
- Factsheet September 2022 Open Download
- Factsheet August 2022 Open Download
- Factsheet July 2022 Open Download
- Factsheet June 2022 Open Download
- Factsheet May 2022 Open Download
- Factsheet April 2022 Open Download
- Factsheet March 2022 Open Download
- Factsheet February 2022 Open Download
- Factsheet January 2022 Open Download
- Factsheet December 2021 Open Download
- Factsheet November 2021 Open Download
- Factsheet October 2021 Open Download
- Factsheet September 2021 Open Download
- Factsheet August 2021 Open Download
- Factsheet July 2021 Open Download
- Factsheet June 2021 Open Download
- Factsheet May 2021 Open Download
- Factsheet April 2021 Open Download
- Factsheet March 2021 Open Download
- Factsheet February 2021 Open Download
- Factsheet January 2021 Open Download
- Factsheet December 2020 Open Download
- Factsheet November 2020 Open Download
- Factsheet October 2020 Open Download
- Factsheet September 2020 Open Download
- Factsheet August 2020 Open Download
- Factsheet July 2020 Open Download
- Factsheet June 2020 Open Download
- Factsheet May 2020 Open Download
- Factsheet April 2020 Open Download
- Factsheet March 2020 Open Download
- Factsheet February 2020 Open Download
- Factsheet January 2020 Open Download
- Factsheet December 2019 Open Download
- Factsheet November 2019 Open Download
- Factsheet October 2019 Open Download
- Factsheet September 2019 Open Download
- Factsheet August 2020 Open Download
- Factsheet July 2019 Open Download
- Factsheet June 2019 Open Download
- Factsheet May 2019 Open Download
- Factsheet April 2019 Open Download
- Factsheet March 2019 Open Download
- Factsheet February 2019 Open Download
- Factsheet January 2019 Open Download
- Factsheet December 2018 Open Download
- Factsheet November 2018 Open Download
- Factsheet October 2018 Open Download
- Factsheet September 2018 Open Download
- Factsheet August 2018 Open Download
- Factsheet July 2018 Open Download
- Factsheet June 2018 Open Download
-
Letters to Investors
Date: July 2026 View letters Hide letters Open
Download
-
Newsletters
View newsletters Hide newsletters Open
Download
- Trojan Global Equity Newsletter No 18 Open Download
- Trojan Global Equity Newsletter No 17 Open Download
- Trojan Global Equity Newsletter No 16 Open Download
- Trojan Global Equity Newsletter No 15 Open Download
- Trojan Global Equity Newsletter No 14 Open Download
- Trojan Global Equity Newsletter No 13 Open Download
- Trojan Global Equity Newsletter No 12 Open Download
- Trojan Global Equity Newsletter No 11 Open Download
- Trojan Global Equity Newsletter No 10 Open Download
- Trojan Global Equity Newsletter No 9 Open Download
- Trojan Global Equity Newsletter No 8 Open Download
- Trojan Global Equity Newsletter No 7 Open Download
- Trojan Global Equity Newsletter No 6 Open Download
- Trojan Global Equity Newsletter No 5 Open Download
- Trojan Global Equity Newsletter No 4 Open Download
- Trojan Global Equity Newsletter No 3 Open Download
- Trojan Global Equity Newsletter No 2 Open Download
- Trojan Global Equity Newsletter No 1 Open Download
-
Fund Information Sheet
Open Download -
Interim Report
Date: July 2025 Open Download -
Annual Report
Date: January 2026 Open Download -
Prospectus & Additional Investor Information
View documents Hide documents Open
Download
- Trojan Funds (Ireland) plc Singapore Information Memorandum Open Download
- Trojan Funds (Ireland) Plc Swiss Consolidated Prospectus Open Download
-
UK Reporting Status
Date: 2026 View documents Hide documents Open
Download
- UK Reporting Status 2025 Open Download
- UK Reporting Status 2024 Open Download
- UK Reporting Status 2023 Open Download
-
UCITS KIID
View documents Hide documents Download
- UCITS KIID I EUR ACCUMULATION Download
- UCITS KIID S GBP ACCUMULATION Download
- UCITS KIID I EUR INCOME Download
- UCITS KIID O GBP ACCUMULATION Download
- UCITS KIID O GBP INCOME Download
- UCITS KIID O EUR ACCUMULATION Download
- UCITS KIID O USD ACCUMULATION Download
- UCITS KIID I GBP ACCUMULATION Download
- UCITS KIID O USD INCOME Download
- UCITS KIID S GBP INCOME Download
- UCITS KIID O EUR INCOME Download
-
Sustainability-related Disclosures
View documents Hide documents Open
Download
-
Shareholder Meetings
View archive Hide archive Open
Download
Trojan Global Equity Fund was domiciled in the UK and authorised as a UK UCITS, which was originally launched as the Trojan Capital Fund, focused on investing in UK equities with the flexibility to invest in overseas equities and other asset classes. The strategy was changed to a global equity strategy in December 2013. The Trojan Global Equity Fund merged with the Trojan Global Equity Fund (Ireland) on 13 December 2024.
This fund is not based in the UK and is not subject to UK sustainable investment labelling and disclosure requirements.
Important Information
Past performance is not a guide to future performance. The value of a fund and any income from it may go down as well as up and investors may get back less than they invested. Changes in rates of exchange may cause the value of investments to go up or down. Returns may increase or decrease as a result of currency fluctuations. This data is provided for information only and should not be reproduced, published or disseminated in any manner. Although Troy considers the data to be reliable, no warranty is given as to its accuracy or completeness. Any comparisons against indices are for illustrative purposes only. For the full fund disclaimer please refer to the Fund factsheet. Please refer to Troy’s Glossary of Terms available here.
Important information for U.S. persons
The securities described on this website are neither available nor offered in the United States of America (including the District of Columbia or any other territory occupied or possessed by the United States of America) or to U.S. persons (including residents of the United States of America, residents within an area subject to its jurisdiction and U.S. persons who are resident outside the United States of America).
How to invest
Find more information on how to invest in this fund and where it is available.
To receive our latest investment updates and commentary, subscribe to our mailing list.

Commentary
August 2026
Your Fund returned +3.3% during the month, compared with +1.8% for the MSCI World Index NR (£).
The Fund’s returns continue to be driven by a recovery in the shares of digital businesses that were previously sold off because of uncertainty surrounding Artificial Intelligence (AI). We have long maintained that the simple distinction between AI’s ‘winners’ and ‘losers’ is too binary and that a more nuanced picture of evolution and adaptation would ultimately emerge. We see this reappraisal process taking a while to play out, and in the meantime, we consider that the Fund contains plenty of value yet to be realised.
Beyond AI, a process of rehabilitation is also evident in several of the Fund’s healthcare companies. Agilent Technologies (‘Agilent’), a provider of analytical tools to the life sciences industry, is a leading example. The company reported impressive financial results in August. Its shares were a top five contributor to the Fund’s returns for the month, reinforcing its place among the Fund’s best performers over the past year.
It has been far from plain sailing for Agilent in recent years. The company and its industry were mired by a post-pandemic slowdown, higher inflation, tariffs, and reduced funding for the life sciences. After several false starts, this malaise now appears to be lifting with recovering growth driven by product innovation, a replacement cycle for aging equipment, and renewed customer investment.
Since first investing in the company in 2019, we have admired Agilent’s business breadth, both geographically and across industries. Agilent’s latent strength in China – widely considered a liability amid slowing growth and rising geopolitical tension – revealed itself in the latest quarter as growth reaccelerated. Outside of its leading position in the life sciences, Agilent also differentiates itself with an attractive presence across food safety, environmental testing, forensics, chemicals and advanced materials. This brings with it exposure to newer, faster-growing opportunities, including testing for PFAS[1] and other ‘forever chemicals’, as well as batteries and semiconductors. Strength in breadth suggests the company’s recovery has room to run.
[1] per- and polyfluoroalkyl substances re a large group of man-made chemicals that do not break down easily in the environment